Portfolio
Team
Strategy
Newsroom
Investor Login
Status:
Exited/Public
Chinook Therapeutics
Zymogenetics
Xenoport
Vivus
Viropharma
Ventirx Pharmaceuticals
Vaxcyte
Tularik
Trubion Pharmaceuticals
Trillium Therapeutics
Posts navigation
Older posts